San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

A patient with acute myeloid leukemia received a bone marrow transplant from a deceased donor, achieved engraftment, and has ...

caused mostly by human leukocyte antigen antibodies destroying transfused platelets. The diagnosis of most of these complications can now be made by immunohematologists, with the aid of specialist ...

Researchers led by Osaka University in Japan have conducted the first human trial using induced pluripotent stem-cell-derived ...

Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with ...

Although myeloma is treatable, it is generally not curable, and advanced therapies like blood stem cell transplantation can ...

First human trial of stem-cell-derived corneal transplants for LSCD shows vision improvement, suggesting a safe and effective ...

Over 200 children received free HLA testing for thalassemia in a successful camp at RMLIMS, aiming to raise awareness and ...

A large cross-sectional study revealed that late-onset axial spondyloarthritis diagnosed after 45 years of age may represent a distinct phenotype from early-onset axial spondyloarthritis.

Caribou is enrolling these patients to confirm the progression-free survival (PFS) trend observed previously with CB-010 product partially matched to the patient for human leukocyte antigens (HLA).